The public registers hold a second record for Bachem Americas. The fuller profile, with 32 active US DMFs and 8 valid CEPs, is at Bachem. Figures on this page cover only this record.
Bachem Americas is an API manufacturer based in United States. It holds 7 active US drug master files and 4 valid CEPs across a filed portfolio of 8 molecules. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 28 June 2024 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Torrance, United States | 2024023 |
| Vista, United States | 3000718309 |
| Molecule | Regulators | Docs |
|---|---|---|
| Desmopressin | EDQM, US FDA | 3 |
| Calcitonin (Salmon) | EDQM | 2 |
| Exenatide | US FDA | 1 |
| Lanreotide | US FDA | 1 |
| Liraglutide | US FDA | 1 |
| Parathyroid Hormone | US FDA | 1 |
| Salmon Calcitonin | US FDA | 1 |
| Vasopressin | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| US FDA | None | 1 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Bachem Americas comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.